Login / Signup

Comments on: Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis.

Yan WangXiu SunJunyan ZhangQi Mei
Published in: Hepatology international (2024)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • hepatitis b virus
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes
  • antiretroviral therapy
  • liver fibrosis